Centerra Gold Announces New Corporate Credit Facility
Get Alerts CG Hot Sheet
Join SI Premium – FREE
TORONTO, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra”) (TSX: CG) announced today it has entered into a new U.S.$400 million four-year revolving credit facility plus a U.S.$200 million accordion feature (the "Credit Facility"). The Credit Facility is led by The Bank of Nova Scotia, National Bank Financial Markets and HSBC Canada Bank and is supported by a syndicate of international financial institutions. The interest rate payable on any outstanding borrowings is LIBOR plus 2.25% to 3.25%. The Credit Facility replaced Centerra’s previous U.S.$500 million revolving credit facility.
The Credit Facility is currently undrawn and may be used for general corporate purposes, including working capital, investments, acquisitions, and capital expenditures. The Credit Facility provides future flexibility, while reducing the Company’s financing costs as the Company’s cash position continues to grow.
About CenterraCenterra Gold Inc. is a Canadian-based gold mining company focused on operating, developing, exploring, and acquiring gold properties in North America, Asia, and other markets worldwide and is one of the largest Western-based gold producers in Central Asia. Centerra operates three mines, the Kumtor Mine in the Kyrgyz Republic, the Mount Milligan Mine in British Columbia, Canada and the Öksüt Mine in Turkey. Centerra's shares trade on the Toronto Stock Exchange (TSX) under the symbol CG. The Company is based in Toronto, Ontario, Canada.
For more information:John W. PearsonVice President, Investor Relations(416) 204-1953[email protected]
Additional information on Centerra is available on the Company’s web site at www.centerragold.com and at SEDAR at www.sedar.com.
A PDF accompanying this announcement is available at: http://ml.globenewswire.com/Resource/Download/bee397d0-cb9e-4c21-8144-b341be9c0328
Source: Centerra Gold Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- Frost & Sullivan Has Officially Released "2026 White Paper on the Development of Global and China's AI Data Service Market"
- HAKLO Announces General Availability of Family Culture App
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
HSBCSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share